Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
26 "Jong-Koo Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Editorials
How we can prevent a resurgence this year
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(4):233-234.   Published online August 30, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0235
  • 273 View
  • 79 Download
PDF
Neglected issues related to the COVID-19 pandemic
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(3):149-150.   Published online June 30, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.14.3.01
  • 597 View
  • 52 Download
PDF
To become a more stronger and safer country
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(2):67-69.   Published online April 28, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0105
  • 696 View
  • 37 Download
PDF
Special Article
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi
Osong Public Health Res Perspect. 2023;14(1):5-14.   Published online February 28, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0026
  • 1,938 View
  • 123 Download
  • 1 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDF
With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases.

Citations

Citations to this article as recorded by  
  • To become a more stronger and safer country
    Jong-Koo Lee
    Osong Public Health and Research Perspectives.2023; 14(2): 67.     CrossRef
Editorials
How we will reach a safer community
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(1):1-4.   Published online February 27, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0057
  • 719 View
  • 44 Download
PDF
Efforts to return to a normal society
Jong-Koo Lee
Osong Public Health Res Perspect. 2022;13(6):391-393.   Published online December 30, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.13.6.01
  • 803 View
  • 52 Download
PDF
What measures should be considered in this 2022-2023 winter season
Jong-Koo Lee
Osong Public Health Res Perspect. 2022;13(5):313-315.   Published online October 28, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0286
  • 1,118 View
  • 53 Download
PDF
Preparedness for the next wave of COVID-19 in the Republic of Korea
Jong-Koo Lee
Osong Public Health Res Perspect. 2022;13(4):239-241.   Published online August 31, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0240
  • 1,565 View
  • 46 Download
PDF
Editorial
The neglected issues of global health security that we should prepare for in our society
Jong-Koo Lee
Osong Public Health Res Perspect. 2022;13(3):171-173.   Published online June 30, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0185
  • 1,742 View
  • 56 Download
PDF
Editorials
Preparedness of primary care responses to the next pandemic
Jong-Koo Lee
Osong Public Health Res Perspect. 2022;13(2):81-83.   Published online April 29, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.0136
  • 1,891 View
  • 44 Download
  • 1 Citations
PDF

Citations

Citations to this article as recorded by  
  • The COVID-19 Pandemic Memoir: Lessons for Future Challenges
    Dalmacito A. Cordero
    Disaster Medicine and Public Health Preparedness.2023;[Epub]     CrossRef
As the incidence of Omicron increases, so will the number of deaths
Jong-Koo Lee
Osong Public Health Res Perspect. 2022;13(1):1-3.   Published online February 28, 2022
DOI: https://doi.org/10.24171/j.phrp.2022.13.1.01
  • 2,284 View
  • 98 Download
PDF
Now is the time to consider measures against next wave of COVID-19
Jong-Koo Lee
Osong Public Health Res Perspect. 2021;12(6):343-345.   Published online December 28, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0338
  • 2,990 View
  • 67 Download
PDF
How can we prepare for this autumn and winter?
Jong-Koo Lee
Osong Public Health Res Perspect. 2021;12(5):275-277.   Published online October 26, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0273
  • 4,441 View
  • 43 Download
PDF
How to deal with the Delta variant this fall
Jong-Koo Lee
Osong Public Health Res Perspect. 2021;12(4):201-202.   Published online August 26, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0217
  • 3,587 View
  • 69 Download
  • 5 Citations
PDF

Citations

Citations to this article as recorded by  
  • A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection
    Mohsen Khosravi
    Pharmacopsychiatry.2022; 55(01): 58.     CrossRef
  • Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform
    Jung Hun Ju, Naery Lee, Sun-hee Kim, Seokkee Chang, Misook Yang, Jihyun Shin, Eunjo Lee, Sunhwa Sung, Jung-Hwan Kim, Jin Tae Hong, Ho Jung Oh
    Osong Public Health and Research Perspectives.2022; 13(1): 4.     CrossRef
  • Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
    Chang Kyung Kang, Hyun Mu Shin, Pyoeng Gyun Choe, Jiyoung Park, Jisu Hong, Jung Seon Seo, Yung Hie Lee, Euijin Chang, Nam Joong Kim, Minji Kim, Yong-Woo Kim, Hang-Rae Kim, Chang-Han Lee, Jun-Young Seo, Wan Beom Park, Myoung-don Oh
    BMC Medicine.2022;[Epub]     CrossRef
  • Impact of national Covid-19 vaccination Campaign, South Korea
    Seonju Yi, Young June Choe, Do Sang Lim, Hye Roen Lee, Jia Kim, Yoo-Yeon Kim, Ryu Kyung Kim, Eun Jung Jang, Sangwon Lee, Eunjoo Park, Seung-Jin Kim, Young-Joon Park
    Vaccine.2022; 40(26): 3670.     CrossRef
  • Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea
    Heui Man Kim, Jee Eun Rhee, Nam-Joo Lee, Sang Hee Woo, Ae Kyung Park, Jaehee Lee, Cheon Kwon Yoo, Eun-Jin Kim
    Virology Journal.2022;[Epub]     CrossRef
The policy art of the “trade-off” for combatting COVID-19
Jong-Koo Lee
Osong Public Health Res Perspect. 2021;12(3):137-138.   Published online June 24, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0150
  • 5,500 View
  • 91 Download
PDF

PHRP : Osong Public Health and Research Perspectives